Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biovail’s Aplenzin Wins FDA Go-ahead

Apr 23 2008

• By Randall Osborne

Related Content

Biovail NDA For New Wellbutrin Formulation Is “Not Approvable”

Jul 20 2007

Biovail Settles For $10 Million On SEC Fraud Charges

Mar 24 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window